SJS Investment Consulting’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64K Sell
118
-278
-70% -$7.25K ﹤0.01% 1659
2026
Q1
$10.8K Buy
396
+147
+59% +$5.22K ﹤0.01% 818
2025
Q4
$10.4K Buy
249
+246
+8,200% +$9.98K ﹤0.01% 776
2025
Q3
$139 Buy
+3
New +$160 ﹤0.01% 1543
2025
Q2
Sell
-126
Closed -$7.01K 1572
2025
Q1
$7.01K Hold
126
﹤0.01% 399
2024
Q4
$5.45K Hold
126
﹤0.01% 424
2024
Q3
$6.46K Hold
126
﹤0.01% 437
2024
Q2
$7.97K Sell
126
-6
-5% -$360 ﹤0.01% 361
2024
Q1
$8.74K Hold
132
﹤0.01% 370
2023
Q4
$13K Hold
132
﹤0.01% 279
2023
Q3
$10.6K Hold
132
﹤0.01% 281
2023
Q2
$10.7K Sell
132
-2
-1% -$187 ﹤0.01% 269
2023
Q1
$16.3K Buy
134
+2
+2% +$272 ﹤0.01% 240
2022
Q4
$17.6K Hold
132
0.01% 244
2022
Q3
$14K Buy
+132
New +$16.9K ﹤0.01% 267
2022
Q1
$21K Buy
127
+1
+0.8% +$190 0.01% 292
2021
Q4
$23K Buy
+126
New +$22.5K 0.01% 255

Other funds holding CNXC

SJS Investment Consulting's CNXC Position: Q2 2026 in Review

SJS Investment Consulting reduced its Concentrix (CNXC) stake by 70% in Q2 2026, selling an estimated $7.25K and leaving 118 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

SJS Investment Consulting first reported a position in CNXC in Q4 2021 and has held it in 17 quarters since. The position peaked at $23K in Q4 2021. 109 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • SJS Investment Consulting held 118 shares of Concentrix worth $2.64K as of Q2 2026.
  • SJS Investment Consulting sold 278 Concentrix shares in Q2 2026, an estimated $7.25K.
  • Concentrix made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1659 holding.
  • SJS Investment Consulting first reported a position in Concentrix in Q4 2021 and has held it in 17 quarters since.
  • SJS Investment Consulting's Concentrix position peaked at $23K in Q4 2021.
  • 109 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.